Home / Feed item / OIRM: When is it time to move from lab to clinic? New approach reviews preclinical data b4 clinical trial: http://www.ncbi.nlm.nih.gov/pubmed/27870924 #PubMedCrawl
OIRM: When is it time to move from lab to clinic? New approach reviews preclinical data b4 clinical trial: http://www.ncbi.nlm.nih.gov/pubmed/27870924 #PubMedCrawl
Our Vision
OIRM will transform the treatment of incurable diseases, making Ontario a global leader in the development and dissemination and dissemination of stem cell-based products and therapies.
